Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Authors
Keywords
Cardiotoxicity, Doxorubicin, Oxidative stress, DNMT 1, Histone deacetylase, micro RNAs
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 139, Issue -, Pages 111708
Publisher
Elsevier BV
Online
2021-05-13
DOI
10.1016/j.biopha.2021.111708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proanthocyanidin alleviates doxorubicin‐induced cardiac injury by inhibiting NF‐ k B pathway and modulating oxidative stress, cell cycle, and fibrogenesis
- (2021) Kadry M. Sadek et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Telomerase therapy attenuates cardiotoxic effects of doxorubicin
- (2021) Shambhabi Chatterjee et al. MOLECULAR THERAPY
- Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway
- (2021) Li Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Hydrogen sulfide ameliorates doxorubicin‑induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway
- (2021) Liangui Nie et al. Molecular Medicine Reports
- Cardiac Protective Effect of Kirenol against Doxorubicin-Induced Cardiac Hypertrophy in H9c2 Cells through Nrf2 Signaling via PI3K/AKT Pathways
- (2021) Abdullah M. Alzahrani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective Effect of Two Alkaloids from Hippophae rhamnoides Linn. against Doxorubicin-Induced Toxicity in H9c2 Cardiomyoblasts
- (2021) Wenna Zhou et al. MOLECULES
- Xinmailong Attenuates Doxorubicin-Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO-1
- (2021) Yu Jiang et al. Oxidative Medicine and Cellular Longevity
- Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity
- (2021) Ke Feng et al. BIOMEDICINE & PHARMACOTHERAPY
- Calycosin-triblock copolymer nanomicelles attenuate doxorubicin-induced cardiotoxicity through upregulation of ERp57
- (2021) Xiaoyan Wang et al. Arabian Journal of Chemistry
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- (2020) Kerstin N. Timm et al. CARDIOVASCULAR DRUGS AND THERAPY
- Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
- (2020) Haixia Xu et al. Frontiers in Physiology
- The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity
- (2020) Muluken Altaye Ayza et al. Oxidative Medicine and Cellular Longevity
- Heat Shock Protein 22 Attenuates Doxorubicin-Induced Cardiotoxicity via Regulating Inflammation and Apoptosis
- (2020) Yin Lan et al. Frontiers in Pharmacology
- Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-κB signaling pathway inhibition
- (2020) Xingjuan Fan et al. NEUROLOGICAL RESEARCH
- Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission
- (2020) Xinyue Liang et al. PHARMACOLOGICAL RESEARCH
- Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
- (2020) Himani Kumari et al. Frontiers in Cardiovascular Medicine
- Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress
- (2020) Dan Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anticancer property of ginsenoside Rh2 from ginseng
- (2020) Xun Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice
- (2020) Yoshiro Tanaka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats
- (2020) Derya Karabulut et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- MiR-181c protects cardiomyocyte injury by preventing cell apoptosis through PI3K/Akt signaling pathway
- (2020) Xiaoli Li et al. Cardiovascular Diagnosis and Therapy
- Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner
- (2020) Wei Yu et al. Cardiovascular Diagnosis and Therapy
- Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage
- (2020) Goowon Yang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats
- (2020) Chengchuang Zhan et al. LIFE SCIENCES
- Management of Blood Cholesterol
- (2019) Francis J. Alenghat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Preventive Role of ACE Inhibitors/Angiotensin-II Receptor Blockers and β–Adrenergic Blockers in Anthracycline and Trastuzumab-Induced Cardiotoxicity.
- (2019) Julia B. Blanter et al. Cardiology in Review
- Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity
- (2019) Jie An et al. CURRENT CANCER DRUG TARGETS
- CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression
- (2019) Henrike Tscheschner et al. PLoS One
- Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis
- (2019) Zahra Tavakoli Dargani et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- PGC1α activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades
- (2019) Dong Liu et al. Aging-US
- Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin‐Induced Heart Failure Through Resolution of Toll‐Like Receptor 2–Mediated Myocardial Inflammation
- (2019) Peng Liu et al. Journal of the American Heart Association
- Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature
- (2019) Yan Chen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway
- (2019) Huiwen Ren et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
- (2018) Kaviyarasi Renu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation
- (2018) Rui Song et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- One-Carbon Metabolism: Linking Nutritional Biochemistry to Epigenetic Programming of Long-Term Development
- (2018) Constance E. Clare et al. Annual Review of Animal Biosciences
- Updates in Anthracycline-Mediated Cardiotoxicity
- (2018) Canan G. Nebigil et al. Frontiers in Pharmacology
- Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
- (2018) Jing Lu et al. Acta Pharmaceutica Sinica B
- Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
- (2017) Peter A Henriksen HEART
- Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
- (2017) Clarissa Ruggeri et al. HEART FAILURE REVIEWS
- LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
- (2017) Yan Xia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Modeling Human Myocardium Exposure to Doxorubicin Defines the Risk of Heart Failure from Low-Dose Doxorubicin
- (2017) Emanuela Salvatorelli et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Intravenous administration of mitochondria for treating experimental Parkinson's disease
- (2017) Xianxun Shi et al. MITOCHONDRION
- Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity
- (2017) André Ferreira et al. TOXICOLOGY
- Impact of Frequency of Multi-Vitamin/Multi-Mineral Supplement Intake on Nutritional Adequacy and Nutrient Deficiencies in U.S. Adults
- (2017) Jeffrey Blumberg et al. Nutrients
- Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
- (2017) Navid Koleini et al. Oncotarget
- Differential roles of caspase-1 and caspase-11 in infection and inflammation
- (2017) Si Ming Man et al. Scientific Reports
- Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
- (2017) Liqun Zhao et al. Scientific Reports
- Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
- (2016) J. J. Bartlett et al. BIOCHEMICAL JOURNAL
- New signal transduction paradigms in anthracycline-induced cardiotoxicity
- (2016) Alessandra Ghigo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
- (2016) Giuseppe Curigliano et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progress on the cardiotoxicity of sunitinib: Prognostic significance, mechanism and protective therapies
- (2016) Yi Yang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia/reperfusion-associated cardiac arrhythmias
- (2016) Istvan Lekli et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation
- (2015) Z Li et al. CELL DEATH AND DIFFERENTIATION
- MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
- (2015) Zhongyi Tong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction
- (2015) Hasahya Tony et al. Oxidative Medicine and Cellular Longevity
- Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
- (2015) L Roca-Alonso et al. Cell Death & Disease
- Renal erythropoietin-producing cells in health and disease
- (2015) Tomokazu Souma et al. Frontiers in Physiology
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin
- (2014) Jenelle Govender et al. JOURNAL OF PINEAL RESEARCH
- Echinochrome A Protects Mitochondrial Function in Cardiomyocytes against Cardiotoxic Drugs
- (2014) Seung Jeong et al. Marine Drugs
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study
- (2014) Laura C. Kobashigawa et al. PLoS One
- Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase
- (2014) Y. Liu et al. Science Translational Medicine
- Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
- (2013) Bonnie Ky et al. CIRCULATION RESEARCH
- Basic concepts of epigenetics
- (2013) Michal Inbar-Feigenberg et al. FERTILITY AND STERILITY
- Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase
- (2013) Mohammad T Elnakish et al. JOURNAL OF PATHOLOGY
- Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor
- (2013) Mayel Gharanei et al. PLoS One
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways
- (2012) Jian Ma et al. CARDIOVASCULAR RESEARCH
- Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced CardiotoxicityIn VitroandIn Vivo
- (2012) Hongbo Wang et al. Evidence-based Complementary and Alternative Medicine
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment
- (2012) Caterina Vacchi-Suzzi et al. PLoS One
- Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle
- (2011) T. T. Nielsen et al. CARDIOVASCULAR RESEARCH
- Non-coding RNAs as regulators of gene expression and epigenetics
- (2011) M. U. Kaikkonen et al. CARDIOVASCULAR RESEARCH
- Activation of AMP-Activated Protein Kinase Contributes to Doxorubicin-Induced Cell Death and Apoptosis in Cultured Myocardial H9c2 Cells
- (2011) Min-Bin Chen et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration
- (2011) Karin G. Haug et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible
- (2011) Eliza A. Hawkes et al. JOURNAL OF CLINICAL ONCOLOGY
- Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
- (2011) Ryan Lister et al. NATURE
- p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury
- (2011) Joyce M. Velez et al. PLoS One
- Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
- (2011) Yang Xu et al. PLoS One
- DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria
- (2011) Lisa S. Shock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice
- (2010) Kaushik Vedam et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
- (2010) Takahiro Horie et al. CARDIOVASCULAR RESEARCH
- Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial
- (2010) Andreas Engert et al. JOURNAL OF CLINICAL ONCOLOGY
- Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction
- (2010) A. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy
- (2010) Rui A. Carvalho et al. TOXICOLOGY
- Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
- (2009) Partha Mukhopadhyay et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis
- (2009) Mylène Gilleron et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Extracellular Heat Shock Protein 60, Cardiac Myocytes, and Apoptosis
- (2009) Se-Chan Kim et al. CIRCULATION RESEARCH
- Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage
- (2009) Elif Tatlidede et al. FREE RADICAL RESEARCH
- Regulation of Rac1 by Simvastatin in Endothelial Cells
- (2009) Ruqin Kou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
- (2009) Satoru Kobayashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alteration of Matrix Metalloproteinases in Selective Left Ventricular Adriamycin-Induced Cardiomyopathy in the Pig
- (2009) Andreas Goetzenich et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Epigenetics: Definition, Mechanisms and Clinical Perspective
- (2009) Cathérine Dupont et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway
- (2008) Wuqiang Zhu et al. CIRCULATION
- Extracellular Release of the Atheroprotective Heat Shock Protein 27 Is Mediated by Estrogen and Competitively Inhibits acLDL Binding to Scavenger Receptor-A
- (2008) Katey Rayner et al. CIRCULATION RESEARCH
- Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity
- (2008) Guo-Chang Fan et al. CIRCULATION RESEARCH
- Erythropoietin Pretreatment Protects Against Acute Chemotherapy Toxicity in Isolated Rat Hearts
- (2008) Amandine Ramond et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statinin Vivo
- (2008) Hyoung Chul Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA methylation landscapes: provocative insights from epigenomics
- (2008) Miho M. Suzuki et al. NATURE REVIEWS GENETICS
- Interaction of anthracyclines with iron responsive element mRNAs
- (2008) Joshua C. Canzoneri et al. NUCLEIC ACIDS RESEARCH
- Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms
- (2008) Zhiwei Xu et al. TOXICOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started